EMA
guidance
· 2016-03-04
Facilitating development of medicines for autism spectrum disorder
Summary
EMA provides guidance to facilitate development of medicines for autism spectrum disorder, outlining considerations to support research and regulatory planning.
Upgrade for the full analysis, importance score, and drug timeline.